Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-047680·AI Biotechnology LLC
Schedule 13G ownership disclosure
Surrozen, Inc.
Common stock, par value $0.00001 per share · CUSIP: 86889P208
Event date: 2025-03-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AI Biotechnology LLC
Shares: 844,563 · Class: 9.9%
- Access Industries Holdings LLC
Shares: 844,563 · Class: 9.9%
- Access Industries Management, LLC
Shares: 844,563 · Class: 9.9%
- Len Blavatnik
Shares: 844,563 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-047680
- Form type
- SCHEDULE 13G
- Filer
- AI Biotechnology LLC
- CIK
- CIK 1942670
- Filed
- Mar 31, 2025
- Reporting period
- Mar 24, 2025
- Description
- Schedule 13G beneficial ownership